PB

Pravin Bharamgonda Patil

Active Director Designated Partner DIN 11138993
DIN 11138993 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Pravin Bharamgonda Patil

Data last updated:

Pravin Bharamgonda Patil is a Designated Partner at Jaysingpur Pharma Llp (since 2025).

DIN 11138993
Primary Designation Designated Partner
First Appointment 04 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Jun 20252025Active

Board colleagues of Pravin Bharamgonda Patil

NameDINCompanyDesignation
Darshan Manojkumar Ugare11138992Jaysingpur Pharma LlpDesignated Partner
Virendra Prakash Karadage11138994Jaysingpur Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Jaysingpur Pharma Llp
Premium access

Shareholding and investment profile for Pravin Bharamgonda Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pravin Bharamgonda Patil

Pravin Bharamgonda Patil currently holds 1 directorship: Jaysingpur Pharma Llp (Designated Partner, since 04 Jun 2025).

Pravin Bharamgonda Patil was first appointed on 04 Jun 2025 as Designated Partner at Jaysingpur Pharma Llp.

The current boards of Pravin Bharamgonda Patil's companies include Darshan Manojkumar Ugare (Jaysingpur Pharma Llp), Virendra Prakash Karadage (Jaysingpur Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available